Startseite Impact of earlier gestational diabetes screening for pregnant people with obesity on maternal and perinatal outcomes
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Impact of earlier gestational diabetes screening for pregnant people with obesity on maternal and perinatal outcomes

  • Teresa A. Hillier EMAIL logo , Kathryn L. Pedula , Keith K. Ogasawara , Kimberly K. Vesco , Caryn Oshiro und Jan L. Van Marter
Veröffentlicht/Copyright: 11. Mai 2022

Abstract

Objectives

Gestational diabetes (GDM) screening at 24–28 weeks’ gestation reduces risk of adverse maternal and perinatal outcomes. While experts recommend first-trimester screening for high-risk patients, including those with obesity, data supporting this recommendation is limited.

Methods

We implemented a systematic population intervention to encourage first-trimester GDM screening by oral glucose tolerance testing in a cohort of pregnant people with obesity in two integrated health systems from 2009 to 2013, and compared outcomes to the same population pre-intervention (2006–2009). Up to five years of postpartum glucose testing results (through 2018) were assessed among GDM cases in the post-intervention group. Primary outcomes were large-for-gestational-age birthweight (LGA); macrosomia; a perinatal composite outcome; gestational hypertension/preeclampsia; cesarean delivery; and medication treatment of GDM.

Results

A total of 40,206 patients (9,156 with obesity) were screened for GDM; 2,672 (6.6%) were diagnosed with GDM. Overall, multivariate adjusted risk for LGA and cesarean delivery were lower following the intervention (LGA: aOR 0.89 [0.82, 0.96]; cesarean delivery: 0.89 [0.85, 0.93]). This difference was more pronounced in patients diagnosed with GDM (LGA: aOR 0.52 [0.39, 0.70]; cesarean delivery 0.78 [0.65, 0.94]); insulin/oral hypoglycemic treatment rates for GDM were also higher post-intervention than pre-intervention (22 vs. 29%; p<0.0001). There were no differences for the other primary outcomes. Only 20% of patients diagnosed with GDM early in pregnancy who had postpartum testing had results in the overt diabetes range, suggesting a spectrum of diabetes detected early in pregnancy.

Conclusions

First trimester GDM screening for pregnant people with obesity may improve GDM-associated outcomes.


Corresponding author: Teresa A. Hillier, MD, MS, Endocrinologist & Distinguished Investigator, Kaiser Permanente Center for Health Research, NW & Hawaii 3800 N. Interstate Avenue, Portland, OR 97227, USA; Center for Health Research, Kaiser Permanente Northwest, Portland, OR, USA; and Center for Integrated Health Care Research, Kaiser Permanente Hawaii, Honolulu, HI, USA, Phone: (503) 335-2400, Fax: (503) 335-2424, E-mail:

Award Identifier / Grant number: 1R01HD058015

Acknowledgments

We thank Neon Brooks, PhD for editorial support and Robin Daily for administrative support.

  1. Research funding: This work was supported by grant award 1R01HD058015 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (to TH). Neither the funding source nor the authors’ institutions had any involvement in the study design; the collection, analysis or interpretation of data; the writing of the report; or in the decision to submit the article for publication.

  2. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: Authors state no conflict of interest.

  4. Informed consent: Informed consent was obtained from all individuals included in this study.

  5. Ethical approval: Research involving human subjects complied with all relevant national regulations and institutional policies and is in accordance with the tenets of the Helsinki Declaration (as revised in 2013). Institutional Review Boards (IRBs) at both institutions approved the early screening intervention and evaluation as part of clinical care as the practice is clinically recommended for patients with obesity. The Kaiser Permanente Northwest IRB approved the study January 16, 2008 and the Kaiser Permanente Hawaii IRB approved the study March 20, 2009. Both IRBs approved waivers for individual consent with their study approval as the intervention was minimal risk, clinically recommended, and conducted as part of clinical care.

References

1. Davidson, KW, Barry, MJ, Mangione, CM, Cabana, M, Caughey, AB, Davis, EM, et al.. Screening for gestational diabetes: US Preventive Services Task Force recommendation statement. JAMA 2021;326:531–8. https://doi.org/10.1001/jama.2021.11922.Suche in Google Scholar PubMed

2. World Health Organization (WHO). Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy. Geneva: World Health Organization (WHO); 2013. https://apps.who.int/iris/bitstream/handle/10665/85975/WHO_NMH_MND_13.2_eng.pdf;jsessionid=B12314EE1151E92CEFB9F80F1F1FD6BF?sequence=1 [Accessed 7 Oct 2021].Suche in Google Scholar

3. Committee on Practice Bulletins—Obstetrics. ACOG practice bulletin No. 190: gestational diabetes mellitus. Obstet Gynecol 2018;131:e49–64.10.1097/AOG.0000000000002501Suche in Google Scholar PubMed

4. American Diabetes Association (ADA). 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2021. Diabetes Care 2021;44(1 Suppl):S15–33. https://doi.org/10.2337/dc21-ad09.Suche in Google Scholar PubMed

5. Hillier, TA, Vesco, KK, Pedula, KL, Beil, T, Whitlock, E, Pettitt, DJ. Screening for gestational diabetes mellitus: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 2008;148:766–75. https://doi.org/10.7326/0003-4819-148-10-200805200-00009.Suche in Google Scholar PubMed

6. International Association of Diabetes and Pregnancy Study Groups (IADPSG) Consensus Panel, Metzger, BE, Gabbe, SG, Persson, B, Buchanan, TA, Catalano, PA, et al.. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010;33:676–82. https://doi.org/10.2337/dc09-1848.Suche in Google Scholar PubMed PubMed Central

7. Hillier, TA, Pedula, KL, Ogasawara, KK, Vesco, KK, Oshiro, CES, Lubarsky, SL, et al.. A pragmatic, randomized clinical trial of gestational diabetes screening. N Engl J Med 2021;384:895–904. https://doi.org/10.1056/nejmoa2026028.Suche in Google Scholar PubMed PubMed Central

8. O’Sullivan, JB, Gellis, SS, Dandrow, RV, Tenney, BO. The potential diabetic and her treatment in pregnancy. Obstet Gynecol 1966;27:683–9.Suche in Google Scholar

9. Hillier, TA, Ogasawara, KK, Pedula, KL, Vesco, KK. Markedly different rates of incident insulin treatment based on universal gestational diabetes mellitus screening in a diverse HMO population. Am J Obstet Gynecol 2013;209:440–9. https://doi.org/10.1016/j.ajog.2013.06.044.Suche in Google Scholar PubMed PubMed Central

10. American Diabetes Association. 14. Management of diabetes in pregnancy: Standards of medical care in diabetes-2021. Diabetes Care 2021;44(1 Suppl):S200–10. https://doi.org/10.2337/dc21-S014.Suche in Google Scholar PubMed

11. The HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008;358:1991–2002. https://doi.org/10.1056/NEJMoa0707943.Suche in Google Scholar PubMed

12. Landon, MB, Spong, CY, Thom, E, Carpenter, MW, Ramin, SM, Casey, B, et al.. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med 2009;361:1339–48. https://doi.org/10.1056/nejmoa0902430.Suche in Google Scholar PubMed PubMed Central

13. Crowther, CA, Hiller, JE, Moss, JR, McPhee, AJ, Jeffries, WS, Robinson, JS, et al.. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 2005;325:2477–86. https://doi.org/10.1056/nejmoa042973.Suche in Google Scholar PubMed

14. Oken, E, Kleinman, KP, Rich-Edwards, J, Gillman, MW. A nearly continuous measure of birth weight for gestational age using a United States national reference. BMC Pediatr 2003;3:6. https://doi.org/10.1186/1471-2431-3-6.Suche in Google Scholar PubMed PubMed Central

15. American College of Obstetricians and Gynecologists Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on hypertension in pregnancy. Obstet Gynecol 2013;122:1122–31. https://doi.org/10.1097/01.AOG.0000437382.03963.88.Suche in Google Scholar PubMed

16. COMET Initiative. A core outcome set for studies of gestational diabetes mellitus prevention and treatment; 2019. https://www.comet-initiative.org/studies/details/686 [Accessed 2 Nov 2021].Suche in Google Scholar

17. The National Academies of Sciences Engineering Medicine. Report updates guidelines on how much weight women should gain during pregnancy; calls on health care providers to help women achieve a healthy weight before and during pregnancy; 2009. https://www.nationalacademies.org/news/2009/05/report-updates-guidelines-on-how-much-weight-women-should-gain-during-pregnancy-calls-on-health-care-providers-to-help-women-achieve-a-healthy-weight-before-and-during-pregnancy [Accessed 7 Oct 2021].Suche in Google Scholar

18. Goldstein, RF, Abell, SK, Ranasinha, S, Misso, M, Boyle, JA, Black, MH, et al.. Association of gestational weight gain with maternal and infant outcomes: a systematic review and meta-analysis. JAMA 2017;317:2207. https://doi.org/10.1001/jama.2017.3635.Suche in Google Scholar PubMed PubMed Central

19. Cheng, YW, Chung, JH, Kurbisch-Block, I, Inturrisi, M, Shafer, S, Caughey, AB. Gestational weight gain and gestational diabetes mellitus: perinatal outcomes. Obstet Gynecol 2008;112:1015–22. https://doi.org/10.1097/aog.0b013e31818b5dd9.Suche in Google Scholar PubMed

20. Hedderson, M, Weiss, N, Sacks, D, Pettitt, D, Selby, J, Quesenberry, C, et al.. Pregnancy weight gain and risk of neonatal complications. Macrosomia, hypoglycemia, and hyperbilirubinemia. Obstet Gynecol 2006;108:1153–61. https://doi.org/10.1097/01.aog.0000242568.75785.68.Suche in Google Scholar PubMed

21. Retnakaran, R, Wen, SW, Tan, H, Zhou, S, Ye, C, Shen, M, et al.. Association of timing of weight gain in pregnancy with infant birth weight. JAMA Pediatr 2018;172:136–42. https://doi.org/10.1001/jamapediatrics.2017.4016.Suche in Google Scholar PubMed PubMed Central

22. Li, M, Hinkle, SN, Grantz, KL, Kim, S, Grewal, J, Grobman, WA, et al.. Glycaemic status during pregnancy and longitudinal measures of fetal growth in a multi-racial US population: a prospective cohort study. Lancet Diabetes Endocrinol 2020;8:292–300. https://doi.org/10.1016/s2213-8587(20)30024-3.Suche in Google Scholar PubMed PubMed Central

23. Hillier, TA, Ogasawara, KK, Pedula, KL, Vesco, KK, Oshiro, CES, Van Marter, JL. Timing of gestational diabetes diagnosis by maternal obesity status: impact on gestational weight gain in a diverse population. J Womens Health (Larchmt) 2020;29:1068–76. https://doi.org/10.1089/jwh.2019.7760.Suche in Google Scholar PubMed PubMed Central

24. Bartha, JL, Martinez-Del-Fresno, P, Comino-Delgado, R. Gestational diabetes mellitus diagnosed during early pregnancy. Am J Obstet Gynecol 2000;182:346–50. https://doi.org/10.1016/s0002-9378(00)70222-5.Suche in Google Scholar PubMed

25. Feghali, MN, Abebe, KZ, Comer, DM, Caritis, S, Catov, JM, Scifres, CM. Pregnancy outcomes in women with an early diagnosis of gestational diabetes mellitus. Diabetes Res Clin Pract 2018;138:177–86. https://doi.org/10.1016/j.diabres.2018.02.004.Suche in Google Scholar PubMed PubMed Central

26. Immanuel, J, Simmons, D. Screening and treatment for early-onset gestational diabetes mellitus: a systematic review and meta-analysis. Curr Diabetes Rep 2017;17:115. https://doi.org/10.1007/s11892-017-0943-7.Suche in Google Scholar PubMed

27. Harper, LM, Jauk, V, Longo, S, Biggio, JR, Szychowski, JM, Tita, AT. Early gestational diabetes screening in obese women: a randomized controlled trial. Am J Obstet Gynecol 2020;222:495.e1–8. https://doi.org/10.1016/j.ajog.2019.12.021.Suche in Google Scholar PubMed PubMed Central

28. Chiefari, E, Quaresima, P, Visconti, F, Mirabelli, M, Brunetti, A. Gestational diabetes and fetal overgrowth: time to rethink screening guidelines. Lancet Diabetes Endocrinol 2020;8:561–2. https://doi.org/10.1016/s2213-8587(20)30189-3.Suche in Google Scholar PubMed

29. McIntyre, HD, Sacks, DA, Barbour, LA, Feig, DS, Catalano, PM, Damm, P, et al.. Issues with the diagnosis and classification of hyperglycemia in early pregnancy. Diabetes Care 2016;39:53–4. https://doi.org/10.2337/dc15-1887.Suche in Google Scholar PubMed

30. Wexler, DJ, Powe, CE, Barbour, LA, Buchanan, T, Coustan, DR, Corcoy, R, et al.. Research gaps in gestational diabetes mellitus: executive summary of a National Institute of Diabetes and Digestive and Kidney Diseases workshop. Obstet Gynecol 2018;132:496–505. https://doi.org/10.1097/aog.0000000000002726.Suche in Google Scholar

31. Blyth, CR, Still, HA. Binomial Confidence Intervals. J Am Stat Assoc 1983;78:108–16. https://doi.org/10.1080/01621459.1983.10477938.Suche in Google Scholar

Received: 2021-11-07
Accepted: 2022-04-07
Published Online: 2022-05-11
Published in Print: 2022-10-26

© 2022 Walter de Gruyter GmbH, Berlin/Boston

Artikel in diesem Heft

  1. Frontmatter
  2. WAPM Guideline
  3. Ultrasound in labor: clinical practice guideline and recommendation by the WAPM-World Association of Perinatal Medicine and the PMF-Perinatal Medicine Foundation
  4. Original Articles – Obstetrics
  5. Racial and ethnic distribution of US randomized controlled trials in obstetrics: a retrospective review
  6. Impact of earlier gestational diabetes screening for pregnant people with obesity on maternal and perinatal outcomes
  7. Variations in uterine closure technique: an institutional survey of obstetricians and implications for patient counseling and prevention of adverse sequelae
  8. Termination of pregnancy in the second trimester – the course of different therapy regimens
  9. Hyponatremia among preeclampsia patients – a potential sign of severity
  10. Effect of combined paracetamol and dexamethasone vs. paracetamol on postoperative nausea vomiting after cesarean section
  11. Lidocaine vs. tramadol vs. placebo wound infiltration for post-cesarean section pain relief: a randomized controlled trial
  12. Does the use of chitosan covered gauze for postpartum hemorrhage reduce the need for surgical therapy including hysterectomy? A databased historical cohort study
  13. The effect of advanced maternal age on perinatal outcomes in nulliparous pregnancies
  14. Evaluating the correlation between amniotic fluid volume and estimated fetal weight in healthy pregnant women
  15. Metabolic characterization of amniotic fluid of fetuses with isolated choroid plexus cyst
  16. Does a cervical pessary reduce the rate of preterm birth in women with a short cervix?
  17. Research progress on N6-methyladenosine in the human placenta
  18. Why are women deciding against birth in alongside midwifery units? A prospective single-center study from Germany
  19. Pregnancy hypothyroidism incidence and complications using the 2011 and 2017 ATA cutoff values. Experience at a maternity hospital in a densely populated area in Mexico City
  20. Expression pattern and clinical significance of microRNA-let-7a and IFN-gamma in placental tissue of patients with preeclampsia with severe features
  21. Original Articles – Fetus
  22. Management of neonates with 35 weeks of gestational age or more with infectious risk factors at birth: opportunities for improvement
Heruntergeladen am 31.10.2025 von https://www.degruyterbrill.com/document/doi/10.1515/jpm-2021-0581/pdf
Button zum nach oben scrollen